Skip to main content
Top
Published in: Clinical and Molecular Allergy 1/2015

Open Access 01-12-2015 | Commentary

AIT (allergen immunotherapy): a model for the “precision medicine”

Authors: Giovanni Passalacqua, Giorgio Walter Canonica

Published in: Clinical and Molecular Allergy | Issue 1/2015

Login to get access

Abstract

The interpretation of medical approaches, especially therapy, evolved rapidly in the last century. Starting from the simple description of symptoms, we moved to the pathophysiological descriptions, to the evidence-based medicine, until the so-called “precision medicine”. This latter can be defined as a structural model aimed at customizing healthcare, with medical decisions/products tailored on an individual patient at a highly detailed level. In this sense, allergen immunotherapy represents an optimal model of “precision medicine”, since we know and describe symptoms, function, aetiological agents at molecular level, and we have the possibility to intervene on the natural history of the disease. If considered under the point of view of pharmaco-economy, that is prescribing the optimal treatment to the right patient, allergen immunotherapy represents an almost-ideal model of precision medicine.
Literature
1.
go back to reference Corpus Hyppocraticum (1839) Émile Littré: Oeuvres Completes (Traduction Nouvelle, avec le texte grec en regard), vol I. J.-B. Baillière, Paris Corpus Hyppocraticum (1839) Émile Littré: Oeuvres Completes (Traduction Nouvelle, avec le texte grec en regard), vol I. J.-B. Baillière, Paris
2.
go back to reference Harvey W (1628) Exercitatio Anatomica de Motu Cordis et Sanguinis in animalibus. Sp Coll Hunterian Y.7.13, Frankfurt Harvey W (1628) Exercitatio Anatomica de Motu Cordis et Sanguinis in animalibus. Sp Coll Hunterian Y.7.13, Frankfurt
3.
go back to reference Virchow RK (1858) Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebenlehre, Berlin Virchow RK (1858) Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebenlehre, Berlin
5.
go back to reference Brasier AR (2013) Identification of innate immune response endotypes in asthma: implications for personalized medicine. Curr Allergy Asthma Rep 13:462–468CrossRefPubMedPubMedCentral Brasier AR (2013) Identification of innate immune response endotypes in asthma: implications for personalized medicine. Curr Allergy Asthma Rep 13:462–468CrossRefPubMedPubMedCentral
6.
go back to reference Agache IO (2013) From phenotypes to endotypes to asthma treatment. Curr Opin Allergy Clin Immunol 13:249–256PubMed Agache IO (2013) From phenotypes to endotypes to asthma treatment. Curr Opin Allergy Clin Immunol 13:249–256PubMed
7.
go back to reference Bieber T (2013) Stratified medicine. Future Medicine Ltd. ISBN: 978-1-78084-318-6 Bieber T (2013) Stratified medicine. Future Medicine Ltd. ISBN: 978-1-78084-318-6
8.
go back to reference Braido F, Holgate S, Canonica GW (2012) From “Blockbusters” to “biosimilars”: an opportunity for patients, medical specialists and health care providers. Pulm Pharmacol Ther 25:483CrossRefPubMed Braido F, Holgate S, Canonica GW (2012) From “Blockbusters” to “biosimilars”: an opportunity for patients, medical specialists and health care providers. Pulm Pharmacol Ther 25:483CrossRefPubMed
9.
10.
11.
go back to reference Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D et al (2014) Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am J Respir Crit Care Med 190:175–184CrossRefPubMedPubMedCentral Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D et al (2014) Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis. Am J Respir Crit Care Med 190:175–184CrossRefPubMedPubMedCentral
12.
go back to reference Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG (2014) Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc 11(4):531–536CrossRefPubMed Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG (2014) Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc 11(4):531–536CrossRefPubMed
15.
go back to reference Fajt ML, Wenzel SE (2015) Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 135:299–310CrossRefPubMed Fajt ML, Wenzel SE (2015) Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol 135:299–310CrossRefPubMed
18.
19.
go back to reference Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M et al (2013) Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 131(5):1288–1296CrossRefPubMed Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M et al (2013) Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 131(5):1288–1296CrossRefPubMed
20.
go back to reference Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S et al (2014) Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 7(1):6CrossRefPubMedPubMedCentral Canonica GW, Cox L, Pawankar R, Baena-Cagnani CE, Blaiss M, Bonini S et al (2014) Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 7(1):6CrossRefPubMedPubMedCentral
21.
go back to reference Passalacqua G, Canonica GW (2015) Allergen immunotherapy: focus on tablets. Ann Allergy Asthma Immunol 115:4–9CrossRefPubMed Passalacqua G, Canonica GW (2015) Allergen immunotherapy: focus on tablets. Ann Allergy Asthma Immunol 115:4–9CrossRefPubMed
22.
go back to reference Passalacqua G (2011) Specific immunotherapy: beyond the clinical scores. Ann Allergy Asthma Immunol 107:401–406CrossRefPubMed Passalacqua G (2011) Specific immunotherapy: beyond the clinical scores. Ann Allergy Asthma Immunol 107:401–406CrossRefPubMed
23.
go back to reference Hankin CS, Cox L (2014) Allergy immunotherapy: what is the evidence for cost saving? Curr Opin Allergy Clin Immunol 14:363–370CrossRefPubMed Hankin CS, Cox L (2014) Allergy immunotherapy: what is the evidence for cost saving? Curr Opin Allergy Clin Immunol 14:363–370CrossRefPubMed
25.
go back to reference Kaul S, May SL, Vieths S (2011) Regulatory environment for allergen-specific immunotherapy. Allergy 66:753–764CrossRefPubMed Kaul S, May SL, Vieths S (2011) Regulatory environment for allergen-specific immunotherapy. Allergy 66:753–764CrossRefPubMed
26.
27.
go back to reference Jameson JL, Longo LS (2015) Precision medicine: personalized, problematic and promising. N Eng J Med 372:2229–2234CrossRef Jameson JL, Longo LS (2015) Precision medicine: personalized, problematic and promising. N Eng J Med 372:2229–2234CrossRef
28.
go back to reference Gustafsson M, Colm EN, Zhang H, Barabási AL, Baranzini S, Brunak S et al (2014) Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Med 6:82CrossRefPubMedPubMedCentral Gustafsson M, Colm EN, Zhang H, Barabási AL, Baranzini S, Brunak S et al (2014) Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Med 6:82CrossRefPubMedPubMedCentral
29.
go back to reference Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J et al (2011) Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 3(7):43CrossRefPubMedPubMedCentral Bousquet J, Anto JM, Sterk PJ, Adcock IM, Chung KF, Roca J et al (2011) Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 3(7):43CrossRefPubMedPubMedCentral
30.
go back to reference Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A et al (2014) Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 44:304–323CrossRefPubMed Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A et al (2014) Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 44:304–323CrossRefPubMed
Metadata
Title
AIT (allergen immunotherapy): a model for the “precision medicine”
Authors
Giovanni Passalacqua
Giorgio Walter Canonica
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Clinical and Molecular Allergy / Issue 1/2015
Electronic ISSN: 1476-7961
DOI
https://doi.org/10.1186/s12948-015-0028-6

Other articles of this Issue 1/2015

Clinical and Molecular Allergy 1/2015 Go to the issue